This is a Validated Antibody Database (VAD) review about Rhesus mon.. CCR7, based on 43 published articles (read how Labome selects the articles), using CCR7 antibody in all methods. It is aimed to help Labome visitors find the most suited CCR7 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CCR7 synonym: C-C chemokine receptor type 7; CC chemokine receptor 7

BioLegend
mouse monoclonal (G043H7)
  • mass cytometry; human; loading ...; fig 2b
BioLegend CCR7 antibody (Biolegend, 353202) was used in mass cytometry on human samples (fig 2b). Cell (2019) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; 1:33; loading ...; fig 6c
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples at 1:33 (fig 6c). Gastroenterology (2019) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 1f
BioLegend CCR7 antibody (BioLegend, 353226) was used in flow cytometry on human samples (fig 1f). Cell (2019) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig s2b
BioLegend CCR7 antibody (Biolegend, 353204) was used in flow cytometry on human samples (fig s2b). Cell (2019) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CCR7 antibody (BioLegend, 353212) was used in flow cytometry on human samples (fig 2a). Cell Rep (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig s5a
BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples (fig s5a). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig s2d
BioLegend CCR7 antibody (BioLegend, 353226) was used in flow cytometry on human samples (fig s2d). Nat Immunol (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig s1d
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig s1d). J Clin Invest (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 5a
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 5a). Mol Ther Nucleic Acids (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 5a
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 5a). J Exp Med (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; fig s2e
BioLegend CCR7 antibody (BioLegend, 353233) was used in flow cytometry on human samples (fig s2e). Cell (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples (fig 1d). J Immunol (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 3a). J Virol (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 4b). J Clin Invest (2017) ncbi
mouse monoclonal (G043H7)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend CCR7 antibody (BioLegend, G043H7) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; African green monkey; loading ...; fig s4
In order to optimize the dosing regimen of neutralizing anti-HIV-1 antibodies, BioLegend CCR7 antibody (biolegend, G043H7) was used in flow cytometry on African green monkey samples (fig s4). Nature (2017) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; 1:50; loading ...; fig s1d
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples at 1:50 (fig s1d). Nat Commun (2017) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; 1:100; loading ...; fig s2
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples at 1:100 (fig s2). JCI Insight (2017) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; Rhesus monkey; loading ...; fig s8a
In order to examine the kinetics of SIV-specific CD8+ T cell cytolytic factor expression in peripheral blood, lymph node, spleen, and gut mucosa from early acute infection through chronic infection, BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on Rhesus monkey samples (fig s8a). PLoS Pathog (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig s1a
In order to describe complete autosomal recessive IL-17RA deficiency in patients with chronic mucocutaneous candidiasis, BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...
In order to characterize gammadelta T cell subsets from healthy humans, BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 2a
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig s8
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig s8). Science (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; fig 1h
In order to characterize side population T cells, BioLegend CCR7 antibody (BioLegend, G043 H7) was used in flow cytometry on human samples (fig 1h). J Clin Invest (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 2c
In order to suggest that the BRD4-p300 signaling cascade promotes antitumor T cell grafts that could be used adoptive immunotherapy, BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 2c). J Clin Invest (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 2a
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples (fig 2a). PLoS Pathog (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; Rhesus monkey; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BioLegend CCR7 antibody (BioLegend, 353208) was used in flow cytometry on Rhesus monkey samples . Nat Med (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; tbl 1
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; fig 1
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 1). Int Immunol (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig s4
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend CCR7 antibody (biolegend, G043H7) was used in flow cytometry on human samples (fig s4). J Immunol (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; fig 3a
In order to analyze HIV progression traits of a selective loss of early differentiated and highly functional PD1high CD4 T cells, BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2015) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 3a
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples (fig 3a). J Immunol (2015) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 4c
In order to discuss the importance of IL-5 positive Th2 cells to allergies, BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 4c). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; fig 4
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 4). J Hematol Oncol (2015) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; fig 1
BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples (fig 1). J Neuroimmunol (2015) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; fig 1
BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples (fig 1). J Infect Dis (2015) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 2c
In order to discuss the therapeutic use of ex vivo-generated Akt-inhibited minor histocompatibility antigen-specific CD8+ T cells, BioLegend CCR7 antibody (BioLegend, G04H7) was used in flow cytometry on human samples (fig 2c). Blood (2014) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human
BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human
BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples . J Virol (2015) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; tbl 1
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (tbl 1). J Gen Virol (2015) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; fig s1
In order to investigate the impact of CCR6(+)CXCR3(+)CCR4(-) cells in latent tuberculosis infection, BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig s1). J Immunol (2014) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 2b
In order to assess how different concentrations of IFN-gamma affect dendritic cells, BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 2b). J Leukoc Biol (2014) ncbi
Articles Reviewed
  1. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  2. Karimzadeh H, Kiraithe M, Oberhardt V, Salimi Alizei E, Bockmann J, Schulze zur Wiesch J, et al. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level. Gastroenterology. 2019;156:1820-1833 pubmed publisher
  3. Mayassi T, Ladell K, Gudjonson H, McLaren J, Shaw D, Tran M, et al. Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease. Cell. 2019;176:967-981.e19 pubmed publisher
  4. Collins P, Cella M, Porter S, Li S, Gurewitz G, Hong H, et al. Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells. Cell. 2019;176:348-360.e12 pubmed publisher
  5. Kim C, Hu B, Jadhav R, Jin J, Zhang H, Cavanagh M, et al. Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells. Cell Rep. 2018;25:2148-2162.e5 pubmed publisher
  6. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher
  7. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
  8. Moysi E, Pallikkuth S, de Armas L, Gonzalez L, Ambrozak D, George V, et al. Altered immune cell follicular dynamics in HIV infection following influenza vaccination. J Clin Invest. 2018;128:3171-3185 pubmed publisher
  9. Wang B, Zuo J, Kang W, Wei Q, Li J, Wang C, et al. Generation of Hutat2:Fc Knockin Primary Human Monocytes Using CRISPR/Cas9. Mol Ther Nucleic Acids. 2018;11:130-141 pubmed publisher
  10. Seki A, Rutz S. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells. J Exp Med. 2018;215:985-997 pubmed publisher
  11. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed publisher
  12. Amodio D, Cotugno N, Macchiarulo G, Rocca S, Dimopoulos Y, Castrucci M, et al. Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination. J Immunol. 2018;200:538-550 pubmed publisher
  13. Moreno Cubero E, Subira D, Sanz de Villalobos E, Parra Cid T, Madejon A, Miquel J, et al. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity. J Virol. 2018;92: pubmed publisher
  14. Matos T, O Malley J, Lowry E, Hamm D, Kirsch I, Robins H, et al. Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing ?? T cell clones. J Clin Invest. 2017;127:4031-4041 pubmed publisher
  15. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  16. Nishimura Y, Gautam R, Chun T, Sadjadpour R, Foulds K, Shingai M, et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature. 2017;543:559-563 pubmed publisher
  17. Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun. 2017;8:14253 pubmed publisher
  18. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed publisher
  19. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  20. Roberts E, Carnathan D, Li H, Shaw G, Silvestri G, Betts M. Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog. 2016;12:e1006135 pubmed publisher
  21. Lévy R, Okada S, Béziat V, Moriya K, Liu C, Chai L, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113:E8277-E8285 pubmed publisher
  22. Ryan P, Sumaria N, Holland C, Bradford C, Izotova N, Grandjean C, et al. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc Natl Acad Sci U S A. 2016;113:14378-14383 pubmed
  23. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  24. Sen D, Kaminski J, Barnitz R, Kurachi M, Gerdemann U, Yates K, et al. The epigenetic landscape of T cell exhaustion. Science. 2016;354:1165-1169 pubmed
  25. Boddupalli C, Nair S, Gray S, Nowyhed H, Verma R, Gibson J, et al. ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells. J Clin Invest. 2016;126:3905-3916 pubmed publisher
  26. Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, et al. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Invest. 2016;126:3479-94 pubmed publisher
  27. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  28. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  29. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed publisher
  30. Setoguchi R. IL-15 boosts the function and migration of human terminally differentiated CD8+ T cells by inducing a unique gene signature. Int Immunol. 2016;28:293-305 pubmed publisher
  31. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  32. Paris R, Petrovas C, Ferrando Martinez S, Moysi E, Boswell K, Archer E, et al. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE. 2015;10:e0144767 pubmed publisher
  33. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  34. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed publisher
  35. Schnorfeil F, Lichtenegger F, Emmerig K, Schlueter M, Neitz J, Draenert R, et al. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol. 2015;8:93 pubmed publisher
  36. Bhargava P, Gocke A, Calabresi P. 1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controls. J Neuroimmunol. 2015;279:20-4 pubmed publisher
  37. Boyle M, Jagannathan P, Bowen K, McIntyre T, Vance H, Farrington L, et al. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015;212:416-25 pubmed publisher
  38. van der Waart A, van de Weem N, Maas F, Kramer C, Kester M, Falkenburg J, et al. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. Blood. 2014;124:3490-500 pubmed publisher
  39. Luetke Eversloh M, Hammer Q, Durek P, Nordström K, Gasparoni G, Pink M, et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 2014;10:e1004441 pubmed publisher
  40. Weiskopf D, Angelo M, Bangs D, Sidney J, Paul S, Peters B, et al. The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes. J Virol. 2015;89:120-8 pubmed publisher
  41. Gerna G, Lilleri D, Fornara C, Bruno F, Gabanti E, Cane I, et al. Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host. J Gen Virol. 2015;96:360-9 pubmed publisher
  42. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed publisher
  43. Svajger U, Obermajer N, Jeras M. IFN-?-rich environment programs dendritic cells toward silencing of cytotoxic immune responses. J Leukoc Biol. 2014;95:33-46 pubmed publisher